Drug Trial Radar · NCT06135155
A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations
Last checked: Nov 20, 2026Latest source record: Apr 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
48
Actual
Start
Nov 6, 2023
Primary completion
Dec 4, 2023
Study completion Mar 18, 2024
Sponsor
- Lead sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Nov 18, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the pharmacokinetics of the two different PEG-rhGH preparations after a single administration.
Conditions
- Pediatric Growth Hormone Deficiency (PGHD)
Interventions
PEG-rhGH with new preparationDrug
A single subcutaneous injection of PEG-rhGH with new preparation
PEG-rhGH with present preparationDrug
A single subcutaneous injection of PEG-rhGH with present preparation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics (Peak Plasma Concentration (Cmax) ) of PEG-rhGH with present and new preparationTime frame: 0 hours -168 hours
- Pharmacokinetics (Area under the concentration-time curve from time zero to time infinity (AUC0-∞)) of PEG-rhGH with present and new preparationTime frame: 0 hours -168 hours
- Pharmacokinetics (Area under the concentration-time curve from time zero to time t (AUC0-t )) of PEG-rhGH with present and new preparationTime frame: 0 hours -168 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Chengdu Xinhua Hospital affiliated to North Sichuan Medical College
Chengdu, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.